Posted on 2 Comments

In Vitro Diagnostics (IVD) Market Report on China Market, Status and Forecast, by Players, Types and Applications

China In Vitro Diagnostics Market report is a brilliant presentation of competition, critical dynamics, competition, regional growth and other important aspects of the In Vitro Diagnostics market. It provides exact market figures and insights including CAGR, market shares, price, revenue, volume, consumption, production, and gross margin.

Request Sample Copy of this Report @ https://dpiresearch.com/reports/china-in-vitro-diagnostics-market/

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.

The market is driven by the number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, the demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.

“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025: Clinical Chemistry,Immunoassay,Molecular Testing,SMBG,Point of Care Testing (POCT), Hematology,Coagulation,Microbiology,Genetic Testing,Infectious Diagnostics,Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.

The report contains a granular analysis of China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025. A comprehensive analysis has been done on the market share of China in vitro diagnostics by application, end-user and company share by revenue.

The report also includes assessment of in vitro diagnostics regulation in China. Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers, restraints, trends and opportunities of China in vitro diagnostics market.

Market Segmentation by Application and Analysis (2012 – 2025)

  • Clinical Chemistry
  • Immunoassay
  • Molecular Testing
  • Self–Monitoring of Blood Glucose (SMBG)
  • Point of Care Testing (POCT)
  • Hematology
  • Coagulation
  • Microbiology
  • Genetic Testing
  • Infectious Diagnostics
  • Histology and Cytology

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Sysmex Corporation
  • Mindray Medical International Limited
  • Beckman Coulter Inc
  • Shanghai Fosun Pharmaceutical Group
  • Thermo Fisher Scientific Inc
  • Hologic Inc
  • Qiagen
  • Cepheid
  • Bio-Rad Laboratories Inc
  • Da An Gene Co. Ltd
  • Shanghai Kehua Bio-Engineering Co. Ltd.

The Latest Industry Data Included in this Report:

  • China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)
  • China In Vitro Diagnostics Market Dynamics
  • China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)
  • China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)
  • China In Vitro Diagnostics Market, Company Share by Revenue, 2017
  • China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017
  • Assessment of In Vitro Diagnostics Regulation in China
  • Major Partnership Deals in China In Vitro Diagnostics Market
  • Recent Developments in China In Vitro Diagnostics Market
  • Overview of Key Companies in China In Vitro Diagnostics Market

1. Executive Summary

2. China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)

3. China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)

4. China In Vitro Diagnostics Market, Company Share by Revenue, 2017

5. China In Vitro Diagnostics Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Trends & Opportunities

6. China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025) 
6.1 Clinical Chemistry
6.2 Immunoassay
6.3 Molecular Testing
6.4 Self–Monitoring of Blood Glucose (SMBG)
6.5 Point of Care Testing (POCT)
6.6 Hematology
6.7 Coagulation
6.8 Microbiology
6.9 Genetic Testing
6.10 Infectious Diagnostics
6.11 Histology and Cytology

7. China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017

8. Assessment of In Vitro Diagnostics Regulation in China

9. Major Partnership Deals in China In Vitro Diagnostics Market

10. Recent Developments in China In Vitro Diagnostics Market

11. Overview of Key Companies in China In Vitro Diagnostics Market
11.1 Roche Diagnostics
11.1.1 Company Overview
11.2 Abbott Laboratories
11.2.1 Company Overview
11.3 Siemens Healthineers
11.3.1 Company Overview
11.4 Sysmex Corporation
11.4.1 Company Overview
11.5 Mindray Medical International Limited
11.5.1 Company Overview
11.6 Beckman Coulter Inc
11.6.1 Company Overview
11.7 Shanghai Fosun Pharmaceutical Group
11.7.1 Company Overview
11.8 Thermo Fisher Scientific Inc
11.8.1 Company Overview
11.9 Hologic Inc
11.9.1 Company Overview
11.10 Qiagen
11.10.1 Company Overview
11.11 Cepheid
11.11.1 Company Overview
11.12 Bio-Rad Laboratories Inc
11.12.1 Company Overview
11.13 Da An Gene Co. Ltd
11.13.1 Company Overview
11.14 Shanghai Kehua Bio–Engineering Co. Ltd.
11.14.1 Company Overview

The report is readily available and can be dispatched immediately after payment confirmation.

More Information @ https://dpiresearch.com/reports/china-in-vitro-diagnostics-market/

Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:

DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. We deliver a wide range of cutting-edge research solutions that help organizations in making better decisions of the business to business needs.

DPI Research provides a high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to using advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for business research led by a team of dynamic industry experts. DPI Research provides real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reaches across the globe with global standards from established markets in North America and Europe to emerging markets in South America, Asia-Pacific, Middle East, and Africa to provide the best business solutions.

Contact Us:
Maria Rai
Head of Business Development
DPI Research | Web: https://dpiresearch.com
Direct Line: +91-766-764-8693
E-mail: sales@dpiresearch.com
Posted on Leave a comment

China In Vitro Diagnostics (IVD) Market 2019

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.

The market is driven by the number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, the demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.

“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025: Clinical Chemistry,Immunoassay,Molecular Testing,SMBG,Point of Care Testing (POCT), Hematology,Coagulation,Microbiology,Genetic Testing,Infectious Diagnostics,Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.

The report contains a granular analysis of China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025. A comprehensive analysis has been done on the market share of China in vitro diagnostics by application, end-user and company share by revenue.

The report also includes assessment of in vitro diagnostics regulation in China. Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers, restraints, trends and opportunities of China in vitro diagnostics market.

Market Segmentation by Application and Analysis (2012 – 2025)

  • Clinical Chemistry
  • Immunoassay
  • Molecular Testing
  • Self–Monitoring of Blood Glucose (SMBG)
  • Point of Care Testing (POCT)
  • Hematology
  • Coagulation
  • Microbiology
  • Genetic Testing
  • Infectious Diagnostics
  • Histology and Cytology

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Sysmex Corporation
  • Mindray Medical International Limited
  • Beckman Coulter Inc
  • Shanghai Fosun Pharmaceutical Group
  • Thermo Fisher Scientific Inc
  • Hologic Inc
  • Qiagen
  • Cepheid
  • Bio-Rad Laboratories Inc
  • Da An Gene Co. Ltd
  • Shanghai Kehua Bio-Engineering Co. Ltd.

The Latest Industry Data Included in this Report:

  • China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)
  • China In Vitro Diagnostics Market Dynamics
  • China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)
  • China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)
  • China In Vitro Diagnostics Market, Company Share by Revenue, 2017
  • China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017
  • Assessment of In Vitro Diagnostics Regulation in China
  • Major Partnership Deals in China In Vitro Diagnostics Market
  • Recent Developments in China In Vitro Diagnostics Market
  • Overview of Key Companies in China In Vitro Diagnostics Market

The report is readily available and can be dispatched immediately after payment confirmation.

More Information @ https://dpiresearch.com/reports/china-in-vitro-diagnostics-market/

Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. We deliver a wide range of cutting-edge research solutions that help organizations in making better decisions of the business to business needs.

DPI Research provides a high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to using advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for business research led by a team of dynamic industry experts. DPI Research provides real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reaches across the globe with global standards from established markets in North America and Europe to emerging markets in South America, Asia-Pacific, Middle East, and Africa to provide the best business solutions.

Contact Us:
Maria Rai
Head of Business Development
DPI Research | Web:
https://dpiresearch.com
Direct Line: +91-766-764-8693
E-mail: sales@dpiresearch.com

Posted on Leave a comment

China In Vitro Diagnostics Market Growth Analysis, Key Insights, Emerging Trends, Future Scope and Resources Outlook by 2021 Along with Top Key Players

The in–vitro diagnostics(IVD) market in China has been growing rapidly in the past few years and is expected to grow steadily in the next few years, with major growth potential in segments such as infectious disease testing, chronic disease testing and diagnosis in early stages of disease. Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle diseases, public health awareness, growing aging population, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories. However, low reimbursement rate, absence of quality products by the local companies, population factors and foreign companies faces difficulty to enter the low end IVD products market are restraining the growth of this market.

Long–term Outlook: The China In Vitro Diagnostics Market is expected to reach more than US$ 10 Billion by 2021 with strong double digit growth rate from 2016 to 2021.

China IVD Market: Segment wise Outlook

Immunoassay has emerged as a significant rapidly growing market segment in China IVD market. Immunoassay test controls nearly XX% market share by the year 2021. Other segments such as Clinical Chemistry, Molecular testing and POCT are poised to be remarkable expansion in the near future. Growing demand for infectious disease testing, chronic disease testing and diagnosis in early stages of disease will usher the China IVD market.

China IVD Market: Companies wise Outlook

Roche is the leading company with more than XX% market share in the China IVD market and is expected to hold its strong position in the market. Sysmex Corporation and Abbott Laboratories are the other top two players in the China IVD market. Mindray and Shanghai Kehua Bioengineering(KHB) are another major participant in this market with a good hold in clinical chemistry, immunoassay and molecular testing segments providing varieties of reagents nationwide and semi–auto and automatic biochemistry analyzers to low and mid–end market users.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market, market segments, company wise sales analysis, regulation, major distributors and laboratories of IVD and outlook of the Chinese IVD companies.

This report titled “China In Vitro Diagnostics(IVD) – Opportunity Assessment, Competitive Landscape and Market Forecasts to 2021” has been analyzed from 10 viewpoints:

1. Market and Forecast (2010 – 2021)
2. Segment Wise Market and Forecast (2010 – 2021)
3. Company Wise IVD Sales and Forecast (2010 – 2021)
4. Regulation and its Latest Development
5. Future Prospects in Attractive In Vitro Diagnostics Segments
6. Regional Trends and Opportunities
7. Main Participants/Contributors
8. Major IVD Product Companies Outlook
9. Major Private Clinical Labs and Diagnostic Services Companies Outlook
10. Market Growth Drivers and Challenges

The following segments of the China In Vitro Diagnostics market are detailed with size and six year forecast.

  • Clinical Chemistry
  • Immunoassay
  • Molecular Testing
  • Self–Monitoring of Blood Glucose (SMBG)
  • Point of Care Testing (POCT)
  • Hematology
  • Coagulation
  • Microbiology

The following companies of the China In Vitro Diagnostics market are detailed with size and six year forecast

  • Roche Diagnostics
  • Abbott Laboratories
  • Mindray Medical International Limited
  • Sysmex Corporation
  • Shanghai Kehua Bio–Engineering Co. Ltd.
  • Other Companies

The following Chinese companies of the China In Vitro Diagnostics market are detailed with company overview and its product portfolio

  • Mindray Medical International Limited
  • Shanghai Fosun Pharmaceutical Group
  • Mingyuan Medicare
  • Da An Gene Co. Ltd.
  • Shanghai Kehua Bio–Engineering Co. Ltd.
  • Zhejiang D.a. Diagnostics Technology Co., Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global
  • BGI – Shenzhen
  • OriGene Technologies

Key Topics Covered

1. Executive Summary

2. China In Vitro Diagnostics Market & Forecast (2010 – 2021)

3. China In Vitro Diagnostics Market Share & Forecast (2010 – 2021)
3.1 China In Vitro Diagnostics Market Share Outlook
3.2 China In Vitro Diagnostics Companies Share Outlook

4. China In Vitro Diagnostics Market – Segment Analysis (2010 – 2021)
4.1 China Clinical Chemistry Market & Forecast
4.2 China Immunoassay Market & Forecast
4.3 China Molecular Testing Market & Forecast
4.4 China Self–Monitoring of Blood Glucose (SMBG) Market & Forecast
4.5 China Point of Care Testing (POCT) Market & Forecast
4.6 China Hematology Market & Forecast
4.7 China Coagulation Market & Forecast
4.8 China Microbiology Market & Forecast

5. China In Vitro Diagnostics Market – Company Wise Sales Analysis (2010 – 2021)
5.1 Roche Diagnostics – China IVD Sales & Forecast
5.2 Abbott Laboratories – China IVD Sales & Forecast
5.3 Mindray Medical International Limited – China IVD Sales & Forecast
5.4 Sysmex Corporation – China IVD Sales & Forecast
5.5 Shanghai Kehua Bio–Engineering Co. Ltd. – China IVD Sales & Forecast
5.6 Other Companies – China IVD Sales & Forecast

6. China IVD – Regulation & its Latest Development

7. China IVD – Future Prospects in Attractive In Vitro Diagnostics Segments

8. China IVD – Regional Trends & Opportunities

9. China IVD – Main Participants/Contributors
9.1 China IVD Market – Main Distributors
9.2 China IVD Market – Major Laboratories
9.3 China IVD Market – Major Foreign & Regional Companies

10. China – Major IVD Product Companies Outlook
10.1 Mindray Medical International Limited
10.2 Shanghai Fosun Pharmaceutical Group
10.3 Mingyuan Medicare
10.4 Da An Gene Co. Ltd
10.5 Shanghai Kehua Bio–Engineering Co. Ltd

11. China – Major Private Clinical Labs & Diagnostic Services Companies Outlook
11.1 Zhejiang D.a. Diagnostics Technology Co., Ltd
11.2 ADICON Clinical Laboratories (Privately held)
11.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
11.4 Kindstar Global
11.5 BGI – Shenzhen
11.6 OriGene Technologies

12. China In Vitro Diagnostics Market – Growth Drivers
12.1 China Healthcare Reforms – A Progress to Date & Next Steps
12.2 Upgradation of Automated Testing Levels & Investment by Government in Hospitals Will Drive the China IVD Industry
12.3 Public Health Awareness & Increased Incidence of Hypertension, Cardio Cerebrovascular Illness, Diabetes, Arthritis & Cancer
12.4 Increasing Number of Private Hospitals & Independent Testing Laboratories Boost the Demand of IVD Testing in China

13. China In Vitro Diagnostics Market – Challenges
13.1 Value Added Markets of New Products & Household Consumption Markets
13.2 Low Reimbursement Rate of the Basic Medical Care Insurance for Clinical Tests Will Discourage the People from IVD Tests.
13.3 Absence of Quality Products By the Local Companies Hindrance the Growth of IVD Market in China
13.4 Population Factors
13.5 Foreign Companies Faces Difficulty to Enter the Low End IVD Products Market in China
13.6 Reimbursement Rates Differ in Many Parts of China Which Creates Problems To Popularizing the IVD Products

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report @ https://dpiresearch.com/reports/china-in-vitro-diagnosticsivd-opportunity-assessment-competitive-landscape-and-market-forecasts-to-2021/

Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com

Customization of the Report: 
DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Contact Info

Maria Rai
Sales Manager 
Call: +91 766 764 8693
Email: sales@dpiresearch.com
Website: https://dpiresearch.com